These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 1117138

  • 1. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 2. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 3. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 4. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW, Shaw MW, Goodson S, Lidin B, Walia AS, Fuson EW.
    J Exp Med; 1977 Feb 01; 145(2):302-13. PubMed ID: 833543
    [Abstract] [Full Text] [Related]

  • 5. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan 01; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 6. Antibody-dependent, cell-mediated cytotoxicity with autochthonous lymphocytes and sera after infection with Moloney sarcoma virus.
    Lamon EW, Hale P, Whitten HD.
    J Natl Cancer Inst; 1976 Feb 01; 56(2):349-55. PubMed ID: 1255765
    [Abstract] [Full Text] [Related]

  • 7. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.
    Lamon EW, Wigzel H, Klein E, Andersson B, Skurzak HM.
    J Exp Med; 1973 Jun 01; 137(6):1472-93. PubMed ID: 4709269
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H, Muchmore AV, Chused TM, Holden HT, Herberman RB.
    J Immunol; 1975 Jan 01; 114(1 Pt 1):206-10. PubMed ID: 122986
    [Abstract] [Full Text] [Related]

  • 9. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL.
    J Natl Cancer Inst; 1983 Mar 01; 70(3):493-7. PubMed ID: 6572738
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR, Redmon LW, Bass LR.
    Cancer Res; 1973 Jan 01; 33(1):171-8. PubMed ID: 4734119
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB, Nelson K.
    Int J Cancer; 1975 Aug 15; 16(2):339-46. PubMed ID: 1150357
    [Abstract] [Full Text] [Related]

  • 12. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW.
    Cancer Res; 1976 Dec 15; 36(12):4552-7. PubMed ID: 1000500
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ, Spann R, Nguyenduc M, Lamon EW.
    J Immunol; 1989 Feb 15; 142(4):1318-24. PubMed ID: 2536772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD, Hellström I.
    J Immunol; 1974 Jun 15; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract] [Full Text] [Related]

  • 17. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A, Bronte V, Mandruzzato S, Zambon A, Calderazzo F, Biasi G, Zanovello P, Collavo D.
    Int J Cancer Suppl; 1992 Jun 15; 7():24-7. PubMed ID: 1385341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO, Jones M, Deleo AB, Oettgen HF, Old LJ.
    J Immunol; 1985 Aug 15; 135(2):1505-9. PubMed ID: 4008930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.